Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tresiba 100 Units/ml Penfill (3ml Each)

Prescription Icon
Prescription Required

Marketer

Novo Nordisk India Pvt Ltd

Salt Composition

Insulin Degludec (100IU)

Overview Tresiba 100 Units/ml Penfill (3ml Each)

Insulin degludec 100 Units/ml Penfill (3ml vial) is a long-acting insulin analog indicated for adults and children with type 1 or type 2 diabetes. This medication provides consistent, 24-hour glycemic control, mitigating diabetic complications. It may be administered alone or in conjunction with rapid-acting insulin or other antidiabetic agents, as directed by your healthcare provider. Subcutaneous injection is recommended, with proper technique demonstrated by your doctor or nurse. Adherence to the prescribed daily dose, ideally at the same time each day, is crucial. While flexibility exists, maintaining at least an 8-hour interval between injections is essential. Discontinuation may result in severe hyperglycemia. This medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as advised by your physician. Hypoglycemia is a prevalent adverse effect; accurate dosing, regular meals, and blood glucose monitoring are key preventative measures. Alcohol consumption can exacerbate hypoglycemia. Other potential side effects include injection site reactions (erythema, edema, lipohypertrophy) and weight gain. Avoid use during hypoglycemic episodes. Prior medical history (renal, hepatic, cardiac disease) should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use.

Primary Ingredients of Tresiba 100 Units/ml Penfill (3ml Each)

No information provided. Please provide the text you wish me to rephrase.

Uses of Tresiba 100 Units/ml Penfill (3ml Each)

High blood sugar condition

Major Benefits of Tresiba 100 Units/ml Penfill (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Tresiba 100 Units/ml Penfill (3ml Each):

  • Auto-antibody formation
  • Headache
  • Injection site reactions (pain, swelling, redness)
  • Severe hypoglycemia
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Upper respiratory tract infection

How to use Tresiba 100 Units/ml Penfill (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

How Tresiba 100 Units/ml Penfill (3ml Each) works:

Degludec insulin (Tresiba 100 units/mL Penfill, 3 mL each) offers prolonged glycemic control throughout the day. Mimicking the action of natural insulin, it promotes glucose uptake by muscle and fat tissues, concurrently reducing hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Tresiba 100 Units/ml Penfill (3ml Each) is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Tresiba 100 Units/ml Penfill (3ml per cartridge) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, corresponding data from human studies remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Tresiba 100 Units/ml Penfill (3ml vials) while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a potential consequence of both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Tresiba 100 Units/ml Penfill (3ml Each). Dosage modification of Tresiba 100 Units/ml Penfill (3ml Each) might be necessary. Physician consultation is recommended. Close and consistent blood glucose level monitoring is strongly suggested.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Tresiba 100 Units/ml Penfill (3ml cartridges). Dosage modification of Tresiba 100 Units/ml Penfill (3ml cartridges) may be necessary. Physician consultation is recommended. Close and consistent blood glucose monitoring is crucial.

What if you forget to take Tresiba 100 Units/ml Penfill (3ml Each) :

Remember to administer your Tresiba 100 Units/ml Penfill (3ml) injection as soon as possible if you miss a dose. However, avoid taking subsequent doses within an 8-hour timeframe.

Facts to Know About Tresiba 100 Units/ml Penfill (3ml Each)

LabelValue
Chemical Type Modified insulin
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tresiba 100 Units/ml Penfill (3ml Each)

Tresiba 100 Units/ml Penfill (3ml Each), an ultra-long-acting insulin, manages high blood sugar in adults and children (aged 1 and up) with type 1 and type 2 diabetes. Mimicking the body's natural insulin, Tresiba helps transfer sugar from the bloodstream to tissues for energy and prevents the liver from releasing excess sugar, thus regulating blood glucose levels.
Tresiba 100 Units/ml Penfill (3ml Each) is administered subcutaneously. Your doctor will teach you the proper injection technique and appropriate injection sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area for each dose; for example, vary your stomach injection site by approximately 1 cm each time. Alternating injection sides (e.g., right side one day, left the next) is also helpful. This rotation minimizes complications like lipodystrophy (fat tissue thickening), irritation, and pain from repeated injections in the same spot. After one to two weeks, switch to a different body area as directed by your doctor. Contact your doctor if you experience any injection-related issues.
Insulin glargine and Tresiba (100 Units/ml Penfill, 3ml) are synthetic insulins for diabetes management, differing in duration. Glargine, a long-acting insulin, provides approximately 24-hour blood sugar control. Tresiba, an ultra-long-acting insulin, offers extended coverage of up to 42 hours.
Tresiba 100 Units/ml Penfill (3ml Each) and insulin detemir are both effective and safe long-acting insulins. Tresiba's key advantage is its extended duration of action (over 40 hours), promoting consistent blood sugar control. Studies suggest Tresiba may also have a slightly reduced hypoglycemia risk.
Tresiba 100 Units/ml Penfill (3ml Each) can be used with other diabetes medications or fast-acting insulins as directed by your doctor. Follow your doctor's prescribed dose and duration for optimal results. Combining Tresiba with thiazolidinediones (TZDs), such as pioglitazone, may increase the risk of heart failure, even in those without a prior history of heart problems; existing heart failure may worsen. Always inform your doctor of all medications you are taking, especially other diabetes medications, as they may interact with Tresiba. Disclose any history of heart problems to your doctor.
Your doctor will recommend lifestyle adjustments crucial for your health. Maintain regular physical activity, eat consistently, and closely monitor your blood sugar. A dietitian can help create a suitable meal plan. Refrain from driving or operating heavy machinery until you understand Tresiba's effects. Avoid alcohol due to potential side effects such as dizziness. Inform your doctor of all other medications you're taking, as they may influence your Tresiba dosage.
Tresiba (100 Units/ml, 3ml Penfill) aids in daily diabetes management. Supplemental short-acting insulin may be necessary to address blood sugar spikes and diabetic ketoacidosis.
Tresiba 100 Units/ml Penfill (3ml) is a basal insulin. Basal insulins, including Glargine, Detemir, and Degludec (sold under various brand names), are slow-acting and administered between meals and at bedtime to manage non-mealtime blood sugar levels.
Basal, or background, insulins—also known as long-acting insulins—provide continuous blood sugar control throughout the day. Their 24-hour absorption profile delivers sustained blood sugar lowering compared to short-acting insulins.
Tresiba 100 Units/ml Penfill (3ml Each) can lead to weight gain in some users, possibly because insulin's anabolic action encourages glucose and fat storage.
Tresiba 100 Units/ml Penfill (3ml Each) doesn't independently raise blood sugar. However, omitting doses, taking less than prescribed, or having other health issues (like infections, stress, irregular eating, or inactivity) can cause blood sugar to rise, potentially increasing your Tresiba needs. If you experience these issues or uncontrolled blood sugar, consult your doctor regarding dosage adjustments.
Tresiba 100 Units/ml Penf...
1,306
MRP 1,440
9% off